• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STAAR SURGICAL COMPANY EVO/EVO+ VISIAN IMPLANTABLE COLLAMER LENS (ICL); PHAKIC INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STAAR SURGICAL COMPANY EVO/EVO+ VISIAN IMPLANTABLE COLLAMER LENS (ICL); PHAKIC INTRAOCULAR LENS Back to Search Results
Model Number VICM5_12.1(-6.5)
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Intraocular Pressure Increased (1937)
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Iop elevation from baseline secondary surgical intervention to remove/replace/reposition the lens is identified in the labeling as a known potential adverse event following icl implantation.Claim # (b)(4).
 
Event or Problem Description
The reporter indicated that following a replacement implantable collamer lens (icl) implantation procedure, the patient experienced elevated iop.Due to elevated iop, medication was administered.The problem was resolved.Cause of even is unknown.There are multiple medical device reports associated with this patient.This report is 1 of 2 total reports.Based on the information provided, the risk assessment for our product, and our experience, we have determined the cause or contribution to the reported issue is not indicative of a manufacturing related issue or product deficiency.Additional information was requested.No further information is available at this time.This file will be re-opened if additional information is provided.
 
Additional Manufacturer Narrative
Corrected data: b5.- a facility representative reported that following a implantable collamer lens (icl) implantation replacement procedure, the patient experienced an elevated iop.Medication was prescribed.Reportedly, '12mmhg.The issue was reported as resolved.However, as per the follow up email, the reporter stated that "since the iop stayed high, brimonidine tartrate was administered only after the lens replacement.Currently, the patient's iop is at a stable lever of 12 mmhg'.Lens remains implanted.There are multiple medical device reports associated with this patient.This report is 1 of 2 total reports.Based on the information provided, the risk assessment for our product, and our experience, we have determined the cause or contribution to the reported issue is not indicative of a manufacturing related issue or product deficiency.H6- investigation type code: 4110- lens work order search-no similar complaint event(s) within associated lots were found.Claim# (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVO/EVO+ VISIAN IMPLANTABLE COLLAMER LENS (ICL)
Common Device Name
PHAKIC INTRAOCULAR LENS
Manufacturer (Section D)
STAAR SURGICAL COMPANY
1911 walker avenue
monrovia CA 91016
Manufacturer (Section G)
STAAR SUGICAL COMPANY
1911 walker avenue
monrovia 91016
Manufacturer Contact
joselene muniz
1911 walker avenue
monrovia, CA 91016
MDR Report Key23968075
Report Number2023826-2026-00008
Device Sequence Number11984066
Product Code MTA
UDI-Device Identifier00840311300204
UDI-Public(01)00840311300204(11)241020(17)270930
Combination Product (Y/N)N
Initial Reporter CountryKS
PMA/510(K) Number
P030016
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2025
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 01/05/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Model NumberVICM5_12.1(-6.5)
Device Catalogue NumberVICM5_12.1
Device Lot NumberN/A
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/17/2025
Supplement Date Received by Manufacturer03/15/2026
Initial Report FDA Received Date01/05/2026
Supplement Report FDA Received Date03/15/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured10/20/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
CARTRIDGE MODEL-UNK, LOT#-UNK.; INJECTOR MODEL-UNK,LOT#-UNK.; UNK-MODEL-UNK, LOT#-UNK.
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-